Theresa I. Shireman, PhD, RPh

Associate Professor, Preventive Medicine & Public Health
Associate Scientist, Landon Center on Aging
Affiliate Faculty, Gerontology Center

Are medications used effectively and appropriately in clinical practice? What is the most cost-effective therapeutic approach in practice? Through observational studies utilizing large administrative databases, Theresa Shireman exercises her skills in pharmacoepidemiology and pharmacoeconomics to solve these and other problems in collaboration with multidisciplinary research teams. Recently, Theresa led a team which investigated bleeding risk outcomes associated with concurrent aspirin and warfarin use in elderly patients with atrial fibrillation. The recently-published bleeding risk model was designed to help clinicians determine which patients are more or less likely to bleed based upon their age, co-morbidities, and use of aspirin. She has also brought together a dynamic research team to study the effectiveness of cardio-protective agents in end-stage renal disease patients through the linkage of two national databases. Her research interests carry over to her teaching responsibilities which include graduate courses on pharmacoepidemiology, and cost-effectiveness and decision analysis.

BS	Pharmacy	Drake University
MS	Pharmacy	University of Iowa
PhD	Pharmacy-economics/Epidemiology/Public Policy	University of Wisconsin-Madison